- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0275
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A multiplex platform for the identification of ovarian cancer biomarkers ; volume:14 ; number:1 ; day:10 ; month:10 ; year:2017 ; pages:1-21 ; date:12.2017
Clinical proteomics ; 14, Heft 1 (10.10.2017), 1-21, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Boylan, Kristin L. M.
- Contributor
-
Geschwind, Kate
Koopmeiners, Joseph S.
Geller, Melissa A.
Starr, Timothy K.
Skubitz, Amy P. N.
SpringerLink (Online service)
- DOI
-
10.1186/s12014-017-9169-6
- URN
-
urn:nbn:de:1111-2017111510709
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:26 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Boylan, Kristin L. M.
- Geschwind, Kate
- Koopmeiners, Joseph S.
- Geller, Melissa A.
- Starr, Timothy K.
- Skubitz, Amy P. N.
- SpringerLink (Online service)
Other Objects (12)
Discovering endometriosis biomarkers with multiplex cytokine arrays
A multiplex serologic platform for diagnosis of tick-borne diseases
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum
Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery
Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
Towards identification of true cancer biomarkers
Biomarkers for hazard identification in humans
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
New prognostic and predictive biomarkers in primary ovarian cancer
Discovering endometriosis biomarkers with multiplex cytokine arrays
A multiplex serologic platform for diagnosis of tick-borne diseases
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum
Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery
Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
Towards identification of true cancer biomarkers
Biomarkers for hazard identification in humans
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer
New prognostic and predictive biomarkers in primary ovarian cancer
Discovering endometriosis biomarkers with multiplex cytokine arrays
A multiplex serologic platform for diagnosis of tick-borne diseases
A two-step strategy for identification of plasma protein biomarkers for endometrial and ovarian cancer
Quantitative proteomic analysis by iTRAQ® for the identification of candidate biomarkers in ovarian cancer serum
Identification of PKP 2/3 as potential biomarkers of ovarian cancer based on bioinformatics and experiments
Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery
Identification of four hub genes as promising biomarkers to evaluate the prognosis of ovarian cancer in silico
A multiplex immunoassay of serum biomarkers for the detection of uveal melanoma
Towards identification of true cancer biomarkers
Biomarkers for hazard identification in humans
Unveiling novel biomarkers for platinum chemoresistance in ovarian cancer